Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
fundings & exits
health
tc
artificial intelligence
balderton capital
boston blog main
business
business sponsored company news
cancer diagnostics
cancer screening
diabetes
dna
dna sequencing
europe
freenome
genetics
genomic medicine
genomic testing
grail
guardant health
heart diseases
helices
ibm watson
life sciences
liquid biopsy
lucence
lucence diagnostics
medical
national blog main
nutrition
predictive medicine
san francisco
san francisco blog main
san francisco top stories
scattering
singapore
software as a service
sophia genetics
startups
What
cancer
6
×
genomic
6
×
medicine
announced
data
today
based
company
diagnostics
diseases
healthcare
leading
lucence
screening
series
startup
tests
access
advisory
aims
algorithms
analysis
analytics
announces
area
balderton
bay
better
big
bioinformatics
biomedical
biopsy
biotech
blood
board
bridges
build
buildout
built
centers
Language
unset
Current search:
cancer
×
genomic
×
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@techcrunch.com
4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com
6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
@venturebeat.com
7 years ago
Seven Bridges Announces Scientific Advisory Board
@WIRED
7 years ago
A cure for cancer, diabetes, and heart disease might be found in your DNA—if doctors can access.
@theverge.com
9 years ago
England will sequence the genomes of 100,000 humans to tackle cancer and rare diseases